Related Experiment Video
Updated: Apr 7, 2026

Method for Measuring the Activity of Deubiquitinating Enzymes in Cell Lines and Tissue Samples
Published on: May 10, 2015
The Deubiquitinating Enzyme USP7 Regulates Androgen Receptor Activity by Modulating Its Binding to Chromatin
Shu-Ting Chen1, Maiko Okada2, Ryuichiro Nakato1
1From the Research Center for Epigenetic Disease, Institute of Molecular and Cellular Biosciences, University of Tokyo, Tokyo 113-0032 and.
Abstract:
The androgen receptor (AR), a nuclear receptor superfamily transcription factor, plays a key role in prostate cancer. AR signaling is the principal target for prostate cancer treatment, but current androgen-deprivation therapies cannot completely abolish AR signaling because of the heterogeneity of prostate cancers. Therefore, unraveling the mechanism of AR reactivation in androgen-depleted conditions can identify effective prostate cancer therapeutic targets. Increasing evidence indicates that AR activity is mediated by the interplay of modifying/demodifying enzymatic co-regulators. To better understand the mechanism of AR transcriptional activity regulation, we used antibodies against AR for affinity purification and identified the deubiquitinating enzyme ubiquitin-specific protease 7, USP7 as a novel AR co-regulator in prostate cancer cells. We showed that USP7 associates with AR in an androgen-dependent manner and mediates AR deubiquitination. Sequential ChIP assays indicated that USP7 forms a complex with AR on androgen-responsive elements of target genes upon stimulation with the androgen 5α-dihydrotestosterone. Further investigation indicated that USP7 is necessary to facilitate androgen-activated AR binding to chromatin. Transcriptome profile analysis of USP7-knockdown LNCaP cells also revealed the essential role of USP7 in the expression of a subset of androgen-responsive genes. Hence, inhibition of USP7 represents a compelling therapeutic strategy for the treatment of prostate cancer.
Insights
The deubiquitinating enzyme USP7 is a novel co-regulator of the androgen receptor (AR) in prostate cancer. Inhibiting USP7 may offer a new therapeutic strategy for treating prostate cancer by blocking AR signaling.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- The androgen receptor (AR) is crucial in prostate cancer, but current therapies are limited by AR signaling heterogeneity.
- Understanding AR reactivation mechanisms is vital for developing new prostate cancer treatments.
Purpose of the Study:
- To identify novel co-regulators of the androgen receptor (AR) involved in prostate cancer.
- To investigate the role of the deubiquitinating enzyme USP7 in AR transcriptional activity.
Main Methods:
- Antibody-based affinity purification to identify AR-interacting proteins.
- Biochemical assays to assess AR deubiquitination and androgen-dependent association.
- Chromatin immunoprecipitation (ChIP) assays to determine USP7-AR complex formation on target gene promoters.
- Transcriptome profiling of USP7-knockdown cells.
Main Results:
- USP7 was identified as a novel AR co-regulator in prostate cancer cells.
- USP7 associates with AR in an androgen-dependent manner and mediates AR deubiquitination.
- USP7 facilitates AR binding to chromatin at androgen-responsive elements and is essential for the expression of key androgen-responsive genes.
Conclusions:
- USP7 plays a critical role in regulating androgen receptor transcriptional activity in prostate cancer.
- USP7 inhibition represents a promising therapeutic strategy for prostate cancer treatment.
More Related Videos
11:36In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones
Published on: July 25, 2019
10:25Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
Published on: November 22, 2024
Related Concept Videos
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Regulation of Expression at Multiple Steps
The Unfolded Protein Response
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...